Citius Oncology
CTOR | NASDAQ
$0.54
-$0.03 (-5.89%)
At close: Nov 16, 2026, 4:00 PM ET
$0.54
-$0.01 (-0.93%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-5.89%
(1D)Rating
46.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #351/1021 (Top 34%)
Key Statistics
Market Data
Market Cap $58.26M
1D Range
0.53 0.58
52W Range
0.49 1.64
Valuation (TTM)
PE -1.13
PB 1.44
EV/EBITDA -1.20
Valuation (NTM)
Forward PE 7.32
Forward PEG 0.02
Price Target $6.00
Cash Flow
FCF Yield -33.8%
SBC Adj. FCF Yield -33.8%
SBC Impact N/A
Margins
Gross Margin 53.1%
Operating Margin -665.6%
FCF Margin -277.3%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
N/A
Dil EPS 3Y | 5Y 9.4% |
N/A
FCF 3Y | 5Y -143.5% |
N/A
Returns
ROA -41.1%
ROE -103.0%
ROIC -88.7%
Financial Health
Net Cash
$6.35M
Current Ratio 0.73
Interest Coverage -86.40
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigationa...
Sector Healthcare
Industry Medical - Pharmaceuticals
Employees 285
IPO Date Dec 8, 2022
Fiscal Year October - September
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CTOR